Responses to systemic therapy in metastatic pheochromocytoma/paraganglioma - A retrospective multi-center cohort study.

We demonstrate in a real-life clinical setting that all current therapies show reasonable efficacy in preventing disease progression, and this is equally true for patients with germline SDHB mutations.